Bavarian Nordic (OTCMKTS:BVNRY) Stock Crosses Above 50-Day Moving Average – Here’s What Happened

Bavarian Nordic (OTCMKTS:BVNRY) crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $10.85 and traded as high as $11.8150. Bavarian Nordic shares last traded at $11.80, with a volume of 1,475 shares trading hands.

Bavarian Nordic Trading Up 0.7%

The stock has a market cap of $2.89 billion, a P/E ratio of 12.27 and a beta of 1.25. The company’s 50 day moving average price is $10.91 and its two-hundred day moving average price is $10.05.

Bavarian Nordic (OTCMKTS:BVNRY) last announced its earnings results on Friday, August 21st. The company reported $0.46 earnings per share (EPS) for the quarter. Bavarian Nordic had a net margin of 24.36% and a return on equity of 11.97%. The company had revenue of $316.47 million during the quarter.

About Bavarian Nordic

Bavarian Nordic A/S is a Denmark-based biotechnology and vaccine company focused on developing, manufacturing and commercializing vaccines for infectious diseases. The company supplies products to government agencies, public-health organizations, healthcare providers and private-sector customers in markets around the world.

Its best-known product is JYNNEOS, also marketed as IMVANEX in Europe and IMVAMUNE in Canada, a non-replicating smallpox and mpox vaccine. Bavarian Nordic also offers vaccines for travelers and other infectious-disease risks, including products targeting rabies, tick-borne encephalitis, typhoid and cholera, as well as selected pediatric and adult immunization needs.

Founded in 1994 and headquartered in Copenhagen, Bavarian Nordic has expanded from a vaccine research company into an international commercial vaccine manufacturer.